Healthy high growth potential

Results

1495

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1495 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
CDR
zł234.501.8%-6.1%zł23.4bzł235.1345.430.7%0.4%Media
MDGL
US$551.252.9%87.4%US$12.6bUS$680.0011.259.6%n/aPharmaceuticals & Biotech
FWRY
ج.م19.06-0.7%46.1%ج.م64.9bج.م22.4524.427.3%n/aDiversified Financials
KEBNI B
SEK 1.08-0.7%-58.6%SEK 296.0mSEK 1.252.690.9%n/aTech
AXSM
US$238.377.5%137.4%US$12.4bUS$282.5117.357.0%n/aPharmaceuticals & Biotech
WAYS
SEK 38.20-2.1%-4.5%SEK 335.0mSEK 58.00203.378.5%0%Tech
AGP
€6.90-2.5%-9.2%€125.8m€8.5725.339.1%n/aCapital Goods
LPK
€14.75-0.7%77.1%€360.7m€22.753.6116.6%0%Tech
MOD
US$230.401.1%118.4%US$12.8bUS$340.86100.749.2%n/aCapital Goods
SAUD3
R$14.971.4%25.2%R$43.8bR$16.6277.543.7%5.4%Healthcare
NVDA
US$196.51-3.3%11.2%US$5.0tUS$302.8329.822.8%0.5%Semiconductors
CORT
US$91.12-0.5%31.8%US$10.2bUS$92.00209.547.8%n/aPharmaceuticals & Biotech
RHM
€1,050.606.1%-37.4%€49.0b€1,697.8546.630.6%1.1%Capital Goods
LITE
US$711.96-7.0%564.3%US$59.4bUS$1,104.89126.256.5%n/aTech
CRDO
US$208.14-1.9%92.8%US$39.7bUS$279.2982.227.7%n/aSemiconductors
2368
NT$810.00-17.3%131.8%NT$452.3bNT$1,576.8836.138.2%1.2%Tech
688270
CN¥60.48-4.8%70.4%CN¥19.2bCN¥185.71120.585.5%0%Semiconductors
688300
CN¥118.76-12.2%99.3%CN¥31.8bCN¥151.0095.237.0%0.4%Materials
688192
CN¥53.60-13.2%-30.6%CN¥26.3bCN¥83.0027.9105.9%n/aPharmaceuticals & Biotech
001389
CN¥150.76-13.5%119.0%CN¥76.2bCN¥248.6761.032.7%0.4%Tech
MX1
AU$0.029-3.3%-53.2%AU$22.4mAU$0.151.3105.5%n/aHealthcare
AV1
AU$0.068-15.0%-51.4%AU$63.9mAU$0.176.6108.4%n/aSoftware
456A
JP¥1,382.00-6.7%n/aJP¥130.0bn/a39.123.4%n/aRetail
7685
JP¥3,065.00-8.5%116.3%JP¥190.1bJP¥4,666.6725.825.5%0.7%Retail
Page 1 of 42